Starting to agree with these statements mustpow. There is no way this deal is in the best interests of shareholders in the present (IO over $60) climate. The fact that DF gets a $600K bonus for setting the deal up is a kick in the teeth and gives him good reason to want the deal to go through.
Q4 should be well in the money and there predicting a loss, will this company ever make any money for its shareholders?
- Forums
- ASX - By Stock
- AGO
- Ann: Letter to Shareholders-AGO.AX
Ann: Letter to Shareholders-AGO.AX, page-41
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGO (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online